Biologic - PDFSEARCH.IO - Document Search Engine

Biologic
Results: 1831

#	Item
91	Benefit Briefs Brought to you by System Benefits Administration Issue #47, May 2015 Add to Reading List Source URL: assets.system.tamus.edu Language: English - Date: 2015-05-05 17:46:43 Medicine Wellness Biosimilar Patient Protection and Affordable Care Act Biologic Food and Drug Administration Pharmacology Clinical research Pharmaceutical sciences
92	FDA Update ORA and Denver District LaTonya M. Mitchell Denver District Director Southwest Regional Office Add to Reading List Source URL: rmras.org Language: English - Date: 2015-05-26 17:27:21 Pharmaceutical sciences Office of Regulatory Affairs Center for Biologics Evaluation and Research Biologic Regulatory affairs Center for Tobacco Products Center for Drug Evaluation and Research Medical device Center for Veterinary Medicine Food and Drug Administration Medicine Health
93	Avaxia Biologics Appoints Deborah S. Hartman, Ph.D. as Vice President, Research LEXINGTON, Mass. – March 26, 2013 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeut Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:28 Monoclonal antibodies AstraZeneca Södertälje Municipality Biologic Pharmaceutical industry TNF inhibitor Pharmacology Pharmaceutical sciences Biotechnology
94	Human Health Therapeutics Life Sciences What we offer Through R&D services, collaborations, and licences, Add to Reading List Source URL: www.nrc-cnrc.gc.ca Language: English - Date: 2015-05-06 08:14:48 Immunogenicity Biologic Polyclonal antibodies Vaccine New Drug Application Biology Immunology Medicine
95	Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease WAYLAND, Mass. – March 10, 2011 – Avaxia Biologics, Inc., a privately-held biotech company using its proprietary pla Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:22 Malnutrition Wheat Autoimmune diseases Coeliac disease Pediatrics Gluten sensitivity National Institute of Diabetes and Digestive and Kidney Diseases Autoimmunity Biologic Medicine Health Immune system
96	Avaxia Biologics is Awarded Patent for its Proprietary Orally Active Antibody for Celiac Disease LEXINGTON, Mass. – December 13, 2011 – Avaxia Biologics, Inc., a privately-held biotech company developing oral antibod Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:23 Wheat Autoimmune diseases Food allergies Sensitivities Diets Coeliac disease Gluten sensitivity Gluten Biologic Medicine Health Biology
97	PRESS RELEASE Sinensis Life Sciences Acquires Spinnovation September 19, 2014, Leiden, Oss, the Netherlands Sinensis Life Sciences B.V., Leiden, the Netherlands (“Sinensis”), announces today that it has acquired Spi Add to Reading List Source URL: www.noviotech.eu Language: English - Date: 2014-11-16 06:26:22 Validation E. sinensis Biologic Research Pharmaceutical sciences Clinical research Biosimilar Biotechnology Drugs
98	Microsoft Word - 106937148_19 Add to Reading List Source URL: orangebookblog.typepad.com Language: English - Date: 2014-05-29 15:29:36 Pharmaceutical industry Biotechnology Food and Drug Administration Monoclonal antibodies Biosimilar Biologic Declaratory judgment Centocor Infliximab Pharmacology Pharmaceutical sciences Medicine
99	Avaxia Biologics, Inc. Awarded Barda Contract for Therapeutic Countermeasure To Help the Nation Respond To a Radiological Emergency WAYLAND, Mass. – August 3, 2011 – Avaxia Biologics, Inc., a privately-held biotech c Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:22 Pharmacology Biomedical Advanced Research and Development Authority United States Department of Health and Human Services Barda Radiobiology Clinical pharmacology Radiation therapy Biologic Office of the Assistant Secretary for Preparedness and Response Medicine Pharmaceutical sciences Health
100	Avaxia Biologics Receives FDA Orphan Drug Designation for AVX-470 for the Treatment of Pediatric Ulcerative Colitis LEXINGTON, Mass. – November 21, 2014 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical co Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-11-21 11:16:42 Immunology Monoclonal antibodies Pharmacology Abdominal pain Inflammatory bowel disease TNF inhibitor Ulcerative colitis Biologic Monoclonal antibody therapy Medicine Health Autoimmune diseases

UPDATE